Diclofenac, ibuprofen, ketoprofen, meclofenamate, mefenamic acid, and naproxen are the NSAIDs specifically approved by the US Food and Drug Administration (FDA) for treatment of dysmenorrhea.
This report contains market size and forecasts of NSAIDs for Dysmenorrhea in global, including the following market information:
Global NSAIDs for Dysmenorrhea Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global NSAIDs for Dysmenorrhea Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five NSAIDs for Dysmenorrhea companies in 2022 (%)
The global NSAIDs for Dysmenorrhea market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Ibuprofen Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of NSAIDs for Dysmenorrhea include IOLCP, Granules Biocause, Strides Shasun, BASF, SI Group, Hisoar, Pfizer Inc, Teva and Mylan, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the NSAIDs for Dysmenorrhea manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NSAIDs for Dysmenorrhea Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global NSAIDs for Dysmenorrhea Market Segment Percentages, by Type, 2022 (%)
Ibuprofen
Celecoxib
Ketoprofen
Others
Global NSAIDs for Dysmenorrhea Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global NSAIDs for Dysmenorrhea Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Pharmacy
Other
Global NSAIDs for Dysmenorrhea Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global NSAIDs for Dysmenorrhea Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NSAIDs for Dysmenorrhea revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies NSAIDs for Dysmenorrhea revenues share in global market, 2022 (%)
Key companies NSAIDs for Dysmenorrhea sales in global market, 2018-2023 (Estimated), (K Units)
Key companies NSAIDs for Dysmenorrhea sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Hisoar
Pfizer Inc
Teva
Mylan
Apotex
Lupin
SANOFI-Aventis
Boehringer-Ingelheim
BEC Chemicals
Shandong Xinhua Pharmaceutical
Hengrui Medicine
Hubei Biocause Heilen Pharmaceutical
Zibo Xinhua-PERRIGO Pharmaceutical
Zhejiang Jiuzhou
Hubei Xunda
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 NSAIDs for Dysmenorrhea Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NSAIDs for Dysmenorrhea Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NSAIDs for Dysmenorrhea Overall Market Size
2.1 Global NSAIDs for Dysmenorrhea Market Size: 2022 VS 2030
2.2 Global NSAIDs for Dysmenorrhea Revenue, Prospects & Forecasts: 2018-2030
2.3 Global NSAIDs for Dysmenorrhea Sales: 2018-2030
3 Company Landscape
3.1 Top NSAIDs for Dysmenorrhea Players in Global Market
3.2 Top Global NSAIDs for Dysmenorrhea Companies Ranked by Revenue
3.3 Global NSAIDs for Dysmenorrhea Revenue by Companies
3.4 Global NSAIDs for Dysmenorrhea Sales by Companies
3.5 Global NSAIDs for Dysmenorrhea Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 NSAIDs for Dysmenorrhea Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers NSAIDs for Dysmenorrhea Product Type
3.8 Tier 1, Tier 2 and Tier 3 NSAIDs for Dysmenorrhea Players in Global Market
3.8.1 List of Global Tier 1 NSAIDs for Dysmenorrhea Companies
3.8.2 List of Global Tier 2 and Tier 3 NSAIDs for Dysmenorrhea Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global NSAIDs for Dysmenorrhea Market Size Markets, 2022 & 2030
4.1.2 Ibuprofen
4.1.3 Celecoxib
4.1.4 Ketoprofen
4.1.5 Others
4.2 By Type - Global NSAIDs for Dysmenorrhea Revenue & Forecasts
4.2.1 By Type - Global NSAIDs for Dysmenorrhea Revenue, 2018-2023
4.2.2 By Type - Global NSAIDs for Dysmenorrhea Revenue, 2023-2030
4.2.3 By Type - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2030
4.3 By Type - Global NSAIDs for Dysmenorrhea Sales & Forecasts
4.3.1 By Type - Global NSAIDs for Dysmenorrhea Sales, 2018-2023
4.3.2 By Type - Global NSAIDs for Dysmenorrhea Sales, 2023-2030
4.3.3 By Type - Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2030
4.4 By Type - Global NSAIDs for Dysmenorrhea Price (Manufacturers Selling Prices), 2018-2030
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global NSAIDs for Dysmenorrhea Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Pharmacy
5.1.5 Other
5.2 By Application - Global NSAIDs for Dysmenorrhea Revenue & Forecasts
5.2.1 By Application - Global NSAIDs for Dysmenorrhea Revenue, 2018-2023
5.2.2 By Application - Global NSAIDs for Dysmenorrhea Revenue, 2023-2030
5.2.3 By Application - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2030
5.3 By Application - Global NSAIDs for Dysmenorrhea Sales & Forecasts
5.3.1 By Application - Global NSAIDs for Dysmenorrhea Sales, 2018-2023
5.3.2 By Application - Global NSAIDs for Dysmenorrhea Sales, 2023-2030
5.3.3 By Application - Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2030
5.4 By Application - Global NSAIDs for Dysmenorrhea Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global NSAIDs for Dysmenorrhea Market Size, 2022 & 2030
6.2 By Region - Global NSAIDs for Dysmenorrhea Revenue & Forecasts
6.2.1 By Region - Global NSAIDs for Dysmenorrhea Revenue, 2018-2023
6.2.2 By Region - Global NSAIDs for Dysmenorrhea Revenue, 2023-2030
6.2.3 By Region - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2030
6.3 By Region - Global NSAIDs for Dysmenorrhea Sales & Forecasts
6.3.1 By Region - Global NSAIDs for Dysmenorrhea Sales, 2018-2023
6.3.2 By Region - Global NSAIDs for Dysmenorrhea Sales, 2023-2030
6.3.3 By Region - Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America NSAIDs for Dysmenorrhea Revenue, 2018-2030
6.4.2 By Country - North America NSAIDs for Dysmenorrhea Sales, 2018-2030
6.4.3 US NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.4.4 Canada NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.4.5 Mexico NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe NSAIDs for Dysmenorrhea Revenue, 2018-2030
6.5.2 By Country - Europe NSAIDs for Dysmenorrhea Sales, 2018-2030
6.5.3 Germany NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.5.4 France NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.5.5 U.K. NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.5.6 Italy NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.5.7 Russia NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.5.8 Nordic Countries NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.5.9 Benelux NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia NSAIDs for Dysmenorrhea Revenue, 2018-2030
6.6.2 By Region - Asia NSAIDs for Dysmenorrhea Sales, 2018-2030
6.6.3 China NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.6.4 Japan NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.6.5 South Korea NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.6.6 Southeast Asia NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.6.7 India NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America NSAIDs for Dysmenorrhea Revenue, 2018-2030
6.7.2 By Country - South America NSAIDs for Dysmenorrhea Sales, 2018-2030
6.7.3 Brazil NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.7.4 Argentina NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa NSAIDs for Dysmenorrhea Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa NSAIDs for Dysmenorrhea Sales, 2018-2030
6.8.3 Turkey NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.8.4 Israel NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.8.5 Saudi Arabia NSAIDs for Dysmenorrhea Market Size, 2018-2030
6.8.6 UAE NSAIDs for Dysmenorrhea Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 IOLCP
7.1.1 IOLCP Corporate Summary
7.1.2 IOLCP Business Overview
7.1.3 IOLCP NSAIDs for Dysmenorrhea Major Product Offerings
7.1.4 IOLCP NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.1.5 IOLCP Key News
7.2 Granules Biocause
7.2.1 Granules Biocause Corporate Summary
7.2.2 Granules Biocause Business Overview
7.2.3 Granules Biocause NSAIDs for Dysmenorrhea Major Product Offerings
7.2.4 Granules Biocause NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.2.5 Granules Biocause Key News
7.3 Strides Shasun
7.3.1 Strides Shasun Corporate Summary
7.3.2 Strides Shasun Business Overview
7.3.3 Strides Shasun NSAIDs for Dysmenorrhea Major Product Offerings
7.3.4 Strides Shasun NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.3.5 Strides Shasun Key News
7.4 BASF
7.4.1 BASF Corporate Summary
7.4.2 BASF Business Overview
7.4.3 BASF NSAIDs for Dysmenorrhea Major Product Offerings
7.4.4 BASF NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.4.5 BASF Key News
7.5 SI Group
7.5.1 SI Group Corporate Summary
7.5.2 SI Group Business Overview
7.5.3 SI Group NSAIDs for Dysmenorrhea Major Product Offerings
7.5.4 SI Group NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.5.5 SI Group Key News
7.6 Hisoar
7.6.1 Hisoar Corporate Summary
7.6.2 Hisoar Business Overview
7.6.3 Hisoar NSAIDs for Dysmenorrhea Major Product Offerings
7.6.4 Hisoar NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.6.5 Hisoar Key News
7.7 Pfizer Inc
7.7.1 Pfizer Inc Corporate Summary
7.7.2 Pfizer Inc Business Overview
7.7.3 Pfizer Inc NSAIDs for Dysmenorrhea Major Product Offerings
7.7.4 Pfizer Inc NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Inc Key News
7.8 Teva
7.8.1 Teva Corporate Summary
7.8.2 Teva Business Overview
7.8.3 Teva NSAIDs for Dysmenorrhea Major Product Offerings
7.8.4 Teva NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.8.5 Teva Key News
7.9 Mylan
7.9.1 Mylan Corporate Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan NSAIDs for Dysmenorrhea Major Product Offerings
7.9.4 Mylan NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.9.5 Mylan Key News
7.10 Apotex
7.10.1 Apotex Corporate Summary
7.10.2 Apotex Business Overview
7.10.3 Apotex NSAIDs for Dysmenorrhea Major Product Offerings
7.10.4 Apotex NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.10.5 Apotex Key News
7.11 Lupin
7.11.1 Lupin Corporate Summary
7.11.2 Lupin NSAIDs for Dysmenorrhea Business Overview
7.11.3 Lupin NSAIDs for Dysmenorrhea Major Product Offerings
7.11.4 Lupin NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.11.5 Lupin Key News
7.12 SANOFI-Aventis
7.12.1 SANOFI-Aventis Corporate Summary
7.12.2 SANOFI-Aventis NSAIDs for Dysmenorrhea Business Overview
7.12.3 SANOFI-Aventis NSAIDs for Dysmenorrhea Major Product Offerings
7.12.4 SANOFI-Aventis NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.12.5 SANOFI-Aventis Key News
7.13 Boehringer-Ingelheim
7.13.1 Boehringer-Ingelheim Corporate Summary
7.13.2 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Business Overview
7.13.3 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Major Product Offerings
7.13.4 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.13.5 Boehringer-Ingelheim Key News
7.14 BEC Chemicals
7.14.1 BEC Chemicals Corporate Summary
7.14.2 BEC Chemicals Business Overview
7.14.3 BEC Chemicals NSAIDs for Dysmenorrhea Major Product Offerings
7.14.4 BEC Chemicals NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.14.5 BEC Chemicals Key News
7.15 Shandong Xinhua Pharmaceutical
7.15.1 Shandong Xinhua Pharmaceutical Corporate Summary
7.15.2 Shandong Xinhua Pharmaceutical Business Overview
7.15.3 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Major Product Offerings
7.15.4 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.15.5 Shandong Xinhua Pharmaceutical Key News
7.16 Hengrui Medicine
7.16.1 Hengrui Medicine Corporate Summary
7.16.2 Hengrui Medicine Business Overview
7.16.3 Hengrui Medicine NSAIDs for Dysmenorrhea Major Product Offerings
7.16.4 Hengrui Medicine NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.16.5 Hengrui Medicine Key News
7.17 Hubei Biocause Heilen Pharmaceutical
7.17.1 Hubei Biocause Heilen Pharmaceutical Corporate Summary
7.17.2 Hubei Biocause Heilen Pharmaceutical Business Overview
7.17.3 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Major Product Offerings
7.17.4 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.17.5 Hubei Biocause Heilen Pharmaceutical Key News
7.18 Zibo Xinhua-PERRIGO Pharmaceutical
7.18.1 Zibo Xinhua-PERRIGO Pharmaceutical Corporate Summary
7.18.2 Zibo Xinhua-PERRIGO Pharmaceutical Business Overview
7.18.3 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Major Product Offerings
7.18.4 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.18.5 Zibo Xinhua-PERRIGO Pharmaceutical Key News
7.19 Zhejiang Jiuzhou
7.19.1 Zhejiang Jiuzhou Corporate Summary
7.19.2 Zhejiang Jiuzhou Business Overview
7.19.3 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Major Product Offerings
7.19.4 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.19.5 Zhejiang Jiuzhou Key News
7.20 Hubei Xunda
7.20.1 Hubei Xunda Corporate Summary
7.20.2 Hubei Xunda Business Overview
7.20.3 Hubei Xunda NSAIDs for Dysmenorrhea Major Product Offerings
7.20.4 Hubei Xunda NSAIDs for Dysmenorrhea Sales and Revenue in Global (2018-2023)
7.20.5 Hubei Xunda Key News
8 Global NSAIDs for Dysmenorrhea Production Capacity, Analysis
8.1 Global NSAIDs for Dysmenorrhea Production Capacity, 2018-2030
8.2 NSAIDs for Dysmenorrhea Production Capacity of Key Manufacturers in Global Market
8.3 Global NSAIDs for Dysmenorrhea Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NSAIDs for Dysmenorrhea Supply Chain Analysis
10.1 NSAIDs for Dysmenorrhea Industry Value Chain
10.2 NSAIDs for Dysmenorrhea Upstream Market
10.3 NSAIDs for Dysmenorrhea Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 NSAIDs for Dysmenorrhea Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of NSAIDs for Dysmenorrhea in Global Market
Table 2. Top NSAIDs for Dysmenorrhea Players in Global Market, Ranking by Revenue (2022)
Table 3. Global NSAIDs for Dysmenorrhea Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global NSAIDs for Dysmenorrhea Revenue Share by Companies, 2018-2023
Table 5. Global NSAIDs for Dysmenorrhea Sales by Companies, (K Units), 2018-2023
Table 6. Global NSAIDs for Dysmenorrhea Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers NSAIDs for Dysmenorrhea Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers NSAIDs for Dysmenorrhea Product Type
Table 9. List of Global Tier 1 NSAIDs for Dysmenorrhea Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 NSAIDs for Dysmenorrhea Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global NSAIDs for Dysmenorrhea Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global NSAIDs for Dysmenorrhea Revenue (US$, Mn), 2023-2030
Table 14. By Type - Global NSAIDs for Dysmenorrhea Sales (K Units), 2018-2023
Table 15. By Type - Global NSAIDs for Dysmenorrhea Sales (K Units), 2023-2030
Table 16. By Application ? Global NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global NSAIDs for Dysmenorrhea Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global NSAIDs for Dysmenorrhea Revenue (US$, Mn), 2023-2030
Table 19. By Application - Global NSAIDs for Dysmenorrhea Sales (K Units), 2018-2023
Table 20. By Application - Global NSAIDs for Dysmenorrhea Sales (K Units), 2023-2030
Table 21. By Region ? Global NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global NSAIDs for Dysmenorrhea Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global NSAIDs for Dysmenorrhea Revenue (US$, Mn), 2023-2030
Table 24. By Region - Global NSAIDs for Dysmenorrhea Sales (K Units), 2018-2023
Table 25. By Region - Global NSAIDs for Dysmenorrhea Sales (K Units), 2023-2030
Table 26. By Country - North America NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2023-2030
Table 28. By Country - North America NSAIDs for Dysmenorrhea Sales, (K Units), 2018-2023
Table 29. By Country - North America NSAIDs for Dysmenorrhea Sales, (K Units), 2023-2030
Table 30. By Country - Europe NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2023-2030
Table 32. By Country - Europe NSAIDs for Dysmenorrhea Sales, (K Units), 2018-2023
Table 33. By Country - Europe NSAIDs for Dysmenorrhea Sales, (K Units), 2023-2030
Table 34. By Region - Asia NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2023-2030
Table 36. By Region - Asia NSAIDs for Dysmenorrhea Sales, (K Units), 2018-2023
Table 37. By Region - Asia NSAIDs for Dysmenorrhea Sales, (K Units), 2023-2030
Table 38. By Country - South America NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2023-2030
Table 40. By Country - South America NSAIDs for Dysmenorrhea Sales, (K Units), 2018-2023
Table 41. By Country - South America NSAIDs for Dysmenorrhea Sales, (K Units), 2023-2030
Table 42. By Country - Middle East & Africa NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2023-2030
Table 44. By Country - Middle East & Africa NSAIDs for Dysmenorrhea Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa NSAIDs for Dysmenorrhea Sales, (K Units), 2023-2030
Table 46. IOLCP Corporate Summary
Table 47. IOLCP NSAIDs for Dysmenorrhea Product Offerings
Table 48. IOLCP NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Granules Biocause Corporate Summary
Table 50. Granules Biocause NSAIDs for Dysmenorrhea Product Offerings
Table 51. Granules Biocause NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 52. Strides Shasun Corporate Summary
Table 53. Strides Shasun NSAIDs for Dysmenorrhea Product Offerings
Table 54. Strides Shasun NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 55. BASF Corporate Summary
Table 56. BASF NSAIDs for Dysmenorrhea Product Offerings
Table 57. BASF NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 58. SI Group Corporate Summary
Table 59. SI Group NSAIDs for Dysmenorrhea Product Offerings
Table 60. SI Group NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Hisoar Corporate Summary
Table 62. Hisoar NSAIDs for Dysmenorrhea Product Offerings
Table 63. Hisoar NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 64. Pfizer Inc Corporate Summary
Table 65. Pfizer Inc NSAIDs for Dysmenorrhea Product Offerings
Table 66. Pfizer Inc NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 67. Teva Corporate Summary
Table 68. Teva NSAIDs for Dysmenorrhea Product Offerings
Table 69. Teva NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 70. Mylan Corporate Summary
Table 71. Mylan NSAIDs for Dysmenorrhea Product Offerings
Table 72. Mylan NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Apotex Corporate Summary
Table 74. Apotex NSAIDs for Dysmenorrhea Product Offerings
Table 75. Apotex NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 76. Lupin Corporate Summary
Table 77. Lupin NSAIDs for Dysmenorrhea Product Offerings
Table 78. Lupin NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 79. SANOFI-Aventis Corporate Summary
Table 80. SANOFI-Aventis NSAIDs for Dysmenorrhea Product Offerings
Table 81. SANOFI-Aventis NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 82. Boehringer-Ingelheim Corporate Summary
Table 83. Boehringer-Ingelheim NSAIDs for Dysmenorrhea Product Offerings
Table 84. Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. BEC Chemicals Corporate Summary
Table 86. BEC Chemicals NSAIDs for Dysmenorrhea Product Offerings
Table 87. BEC Chemicals NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 88. Shandong Xinhua Pharmaceutical Corporate Summary
Table 89. Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Product Offerings
Table 90. Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 91. Hengrui Medicine Corporate Summary
Table 92. Hengrui Medicine NSAIDs for Dysmenorrhea Product Offerings
Table 93. Hengrui Medicine NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 94. Hubei Biocause Heilen Pharmaceutical Corporate Summary
Table 95. Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Product Offerings
Table 96. Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Zibo Xinhua-PERRIGO Pharmaceutical Corporate Summary
Table 98. Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Product Offerings
Table 99. Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 100. Zhejiang Jiuzhou Corporate Summary
Table 101. Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Product Offerings
Table 102. Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 103. Hubei Xunda Corporate Summary
Table 104. Hubei Xunda NSAIDs for Dysmenorrhea Product Offerings
Table 105. Hubei Xunda NSAIDs for Dysmenorrhea Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 106. NSAIDs for Dysmenorrhea Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2023 (K Units)
Table 107. Global NSAIDs for Dysmenorrhea Capacity Market Share of Key Manufacturers, 2020-2023
Table 108. Global NSAIDs for Dysmenorrhea Production by Region, 2018-2023 (K Units)
Table 109. Global NSAIDs for Dysmenorrhea Production by Region, 2023-2030 (K Units)
Table 110. NSAIDs for Dysmenorrhea Market Opportunities & Trends in Global Market
Table 111. NSAIDs for Dysmenorrhea Market Drivers in Global Market
Table 112. NSAIDs for Dysmenorrhea Market Restraints in Global Market
Table 113. NSAIDs for Dysmenorrhea Raw Materials
Table 114. NSAIDs for Dysmenorrhea Raw Materials Suppliers in Global Market
Table 115. Typical NSAIDs for Dysmenorrhea Downstream
Table 116. NSAIDs for Dysmenorrhea Downstream Clients in Global Market
Table 117. NSAIDs for Dysmenorrhea Distributors and Sales Agents in Global Market
List of Figures
Figure 1. NSAIDs for Dysmenorrhea Segment by Type
Figure 2. NSAIDs for Dysmenorrhea Segment by Application
Figure 3. Global NSAIDs for Dysmenorrhea Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global NSAIDs for Dysmenorrhea Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global NSAIDs for Dysmenorrhea Revenue, 2018-2030 (US$, Mn)
Figure 7. NSAIDs for Dysmenorrhea Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by NSAIDs for Dysmenorrhea Revenue in 2022
Figure 9. By Type - Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2030
Figure 10. By Type - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2030
Figure 11. By Type - Global NSAIDs for Dysmenorrhea Price (US$/Unit), 2018-2030
Figure 12. By Application - Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2030
Figure 13. By Application - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2030
Figure 14. By Application - Global NSAIDs for Dysmenorrhea Price (US$/Unit), 2018-2030
Figure 15. By Region - Global NSAIDs for Dysmenorrhea Sales Market Share, 2018-2030
Figure 16. By Region - Global NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2030
Figure 17. By Country - North America NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2030
Figure 18. By Country - North America NSAIDs for Dysmenorrhea Sales Market Share, 2018-2030
Figure 19. US NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 20. Canada NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 21. Mexico NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 22. By Country - Europe NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2030
Figure 23. By Country - Europe NSAIDs for Dysmenorrhea Sales Market Share, 2018-2030
Figure 24. Germany NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 25. France NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 26. U.K. NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 27. Italy NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 28. Russia NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 29. Nordic Countries NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 30. Benelux NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 31. By Region - Asia NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2030
Figure 32. By Region - Asia NSAIDs for Dysmenorrhea Sales Market Share, 2018-2030
Figure 33. China NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 34. Japan NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 35. South Korea NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 36. Southeast Asia NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 37. India NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 38. By Country - South America NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2030
Figure 39. By Country - South America NSAIDs for Dysmenorrhea Sales Market Share, 2018-2030
Figure 40. Brazil NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 41. Argentina NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - Middle East & Africa NSAIDs for Dysmenorrhea Revenue Market Share, 2018-2030
Figure 43. By Country - Middle East & Africa NSAIDs for Dysmenorrhea Sales Market Share, 2018-2030
Figure 44. Turkey NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 45. Israel NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 46. Saudi Arabia NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 47. UAE NSAIDs for Dysmenorrhea Revenue, (US$, Mn), 2018-2030
Figure 48. Global NSAIDs for Dysmenorrhea Production Capacity (K Units), 2018-2030
Figure 49. The Percentage of Production NSAIDs for Dysmenorrhea by Region, 2022 VS 2030
Figure 50. NSAIDs for Dysmenorrhea Industry Value Chain
Figure 51. Marketing Channels
